Briviact

Product manufactured by Ucb, Inc.

Application Nr Approved Date Route Status External Links
NDA205836 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Briviact Is Indicated For The Treatment Of Partial-Onset Seizures In Patients 4 Years Of Age And Older. As The Safety Of Briviact Injection In Pediatric Patients Has Not Been Established, Briviact Injection Is Indicated For The Treatment Of Partial-Onset Seizures Only In Adult Patients (16 Years Of Age And Older). Briviact Is Indicated For The Treatment Of Partial-Onset Seizures In Patients 4 Years Of Age And Older. As The Safety Of Briviact Injection In Pediatric Patients Has Not Been Established, Briviact Injection Is Indicated For The Treatment Of Partial-Onset Seizures Only In Adult Patients (16 Years Of Age And Older) ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Brivaracetam BRIVARACETAM ZINC3979899

Comments